Muscle damage progression in Duchenne muscular dystrophy evaluated by a new quantitative computed tomography method.

The progression of muscle damage was studied in the lower extremity and trunk muscles of patients with Duchenne muscular dystrophy (DMD) with a new quantitative computed tomography (CT) method. The degree of muscle fiber loss and fat tissue replacement was quantified using the indices of percent cross-sectional area (%CSA) of muscle and fat, or the percentages of the area having the CT numbers of normal muscle and fat. A cross-sectional study in 71 patients showed that as the disability stage progressed, both CT number and %CSA of muscle decreased while %CSA of fat increased. The rate of progression was different for each muscle, and the order of involvement was clarified. The CT findings were also significantly correlated with muscle strength, indicating validity of our method. Our findings of the natural course of muscle involvement would be useful in providing appropriate rehabilitative care as well as assessing the efficacy of therapeutic interventions.

[1]  Beasley Wc.  Quantitative muscle testing: principles and applications to research and clinical services. , 1961 .

[2]  M. Watkins,et al.  Early muscular dystrophy: differential patterns of weakness in duchenne, limb-girdle and facioscapulohumeral types. , 1966, Archives of physical medicine and rehabilitation.

[3]  D. Wilkie,et al.  CLINICAL USE OF NUCLEAR MAGNETIC RESONANCE IN THE INVESTIGATION OF MYOPATHY , 1982, The Lancet.

[4]  Meigen Liu.  THE PROGRESSION OF MUSCLE DAMAGE IN DUCHENNE MUSCULAR DYSTROPHY , 1989 .

[5]  R. Braddom,et al.  Over-work weakness in facioscapulohuumeral muscular dystrophy. , 1971, Archives of physical medicine and rehabilitation.

[6]  F. H. Tyler,et al.  Assessment of muscle strength in Duchenne muscular dystrophy , 1977, Neurology.

[7]  T. Morimoto,et al.  [Computed tomography (CT) of the skeletal muscle in neuromuscular disorders: a comparison of CT with histological findings]. , 1987, No to hattatsu = Brain and development.

[8]  J. Opitz,et al.  Small-caliber skeletal muscle fibers do not suffer deleterious consequences of dystrophic gene expression. , 1986, American journal of medical genetics.

[9]  J. Markisz,et al.  MR appearance of cervical pregnancy. , 1990, Journal of computer assisted tomography.

[10]  G. C. Knowlton,et al.  Overwork weakness in partially denervated skeletal muscle. , 1958, Clinical orthopaedics.

[11]  Eric P. Hoffman,et al.  Dystrophin: The protein product of the duchenne muscular dystrophy locus , 1987, Cell.

[12]  Y. Motoyoshi,et al.  [Computed tomography in Duchenne type muscular dystrophy--morphological stages based on the computed tomographical findings]. , 1985, Rinsho shinkeigaku = Clinical neurology.

[13]  A. Baert,et al.  Computed tomography of the normal and pathologic muscular system. , 1980, Radiology.

[14]  H. Blau,et al.  Fast muscle fibers are preferentially affected in Duchenne muscular dystrophy , 1988, Cell.

[15]  E C McCullough,et al.  Factors affecting the use of quantitative information from a CT scanner. , 1977, Radiology.

[16]  C. Swinyard,et al.  Gradients of functional ability of importance in rehabilitation of patients with progressive muscular and neuromuscular diseases. , 1957, Archives of physical medicine and rehabilitation.

[17]  Hideo Sugita,et al.  Immunostaining of skeletal and cardiac muscle surface membrane with antibody against Duchenne muscular dystrophy peptide , 1988, Nature.

[18]  D. Schellinger,et al.  Computed Tomographic Patterns of Pseudohypertrophic Muscular Dystrophy: Preliminary Results , 1977, Journal of computer assisted tomography.

[19]  D. Caudrey,et al.  PROGRESSION OF MUSCULAR DYSTROPHY ASSESSED BY COMPUTED TOMOGRAPHY , 1984, Developmental medicine and child neurology.

[20]  V. Dubowitz,et al.  Quantitation of muscle function in children: A prospective study in duchenne muscular dystrophy , 1982, Muscle & nerve.

[21]  D. Newham,et al.  ROLE OF MECHANICAL DAMAGE IN PATHOGENESIS OF PROXIMAL MYOPATHY IN MAN , 1984, The Lancet.

[22]  L. Kunkel,et al.  Dystrophin: the protein product of the Duchene muscular dystrophy locus. 1987. , 1992, Biotechnology.

[23]  Sidney Leeman,et al.  DETECTION OF PATHOLOGICAL CHANGE IN DYSTROPHIC MUSCLE WITH B-SCAN ULTRASOUND IMAGING , 1980, The Lancet.

[24]  R. H. T. Edwards,et al.  Size and composition of the calf and quadriceps muscles in Duchenne muscular dystrophy A tomographic and histochemical study , 1983, Journal of the Neurological Sciences.

[25]  K. Hachisuka.  OVERWORK WEAKNESS INDUCED BY FREE RUNNING IN EXPERIMENTAL ACRYLAMIDE NEUROPATHY RATS , 1983 .